These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6477298)
1. Abnormalities of high density lipoproteins in homozygous familial hypercholesterolemia. Goldberg RB; Fless GM; Baker SG; Joffe BI; Getz GS; Scanu AM; Seftel HC Arteriosclerosis; 1984; 4(5):472-8. PubMed ID: 6477298 [TBL] [Abstract][Full Text] [Related]
2. Serum lipid and apolipoprotein A and B levels in familial hypercholesterolemia. Craig IH; Poulis P; Hill G Aust N Z J Med; 1983 Jun; 13(3):241-6. PubMed ID: 6579937 [TBL] [Abstract][Full Text] [Related]
3. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype. Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609 [TBL] [Abstract][Full Text] [Related]
4. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL]. Breier C; Lisch HJ; Drexel H; Braunsteiner H Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113 [TBL] [Abstract][Full Text] [Related]
5. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo. Bilheimer DW; Stone NJ; Grundy SM J Clin Invest; 1979 Aug; 64(2):524-33. PubMed ID: 222811 [TBL] [Abstract][Full Text] [Related]
6. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia. Guérin M; Dolphin PJ; Talussot C; Gardette J; Berthézène F; Chapman MJ Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1359-68. PubMed ID: 7670950 [TBL] [Abstract][Full Text] [Related]
7. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia. Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647 [TBL] [Abstract][Full Text] [Related]
8. Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia. Tilly-Kiesi M; Tikkanen MJ J Lab Clin Med; 1992 Jul; 120(1):103-10. PubMed ID: 1613316 [TBL] [Abstract][Full Text] [Related]
9. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Kwiterovich PO; White S; Forte T; Bachorik PS; Smith H; Sniderman A Arteriosclerosis; 1987; 7(3):211-25. PubMed ID: 3593067 [TBL] [Abstract][Full Text] [Related]
10. Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia. Gibson JC; Goldberg RB; Rubinstein A; Ginsberg HN; Brown WV; Baker S; Joffe BI; Seftel HC Arteriosclerosis; 1987; 7(4):401-7. PubMed ID: 3606467 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency. Breckenridge WC; Alaupovic P; Cox DW; Little JA Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621 [TBL] [Abstract][Full Text] [Related]
13. Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system. Koizumi J; Inazu A; Fujita H; Takeda M; Uno Y; Kajinami K; Mabuchi H; Takeda R Atherosclerosis; 1988 Nov; 74(1-2):1-8. PubMed ID: 3145747 [TBL] [Abstract][Full Text] [Related]
14. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia. Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722 [TBL] [Abstract][Full Text] [Related]
15. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia. Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443 [TBL] [Abstract][Full Text] [Related]
16. ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia. Cubedo J; Padró T; Alonso R; Mata P; Badimon L J Lipid Res; 2016 Jun; 57(6):1059-73. PubMed ID: 27112635 [TBL] [Abstract][Full Text] [Related]
17. Effects of n-3 and n-6 fatty acid-enriched diets on plasma lipoproteins and apolipoproteins in heterozygous familial hypercholesterolemia. Friday KE; Failor RA; Childs MT; Bierman EL Arterioscler Thromb; 1991; 11(1):47-54. PubMed ID: 1988003 [TBL] [Abstract][Full Text] [Related]
18. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia. Inazu A; Koizumi J; Mabuchi H; Kajinami K; Takeda R Horm Metab Res; 1992 Jun; 24(6):284-8. PubMed ID: 1634194 [TBL] [Abstract][Full Text] [Related]
19. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Yamashita S; Hui DY; Wetterau JR; Sprecher DL; Harmony JA; Sakai N; Matsuzawa Y; Tarui S Metabolism; 1991 Jul; 40(7):756-63. PubMed ID: 1870431 [TBL] [Abstract][Full Text] [Related]
20. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia. Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]